MedTrace Logo

Blood Biomarkers in Electroconvulsive Therapy

NCT05515159 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2024-10-10

No results posted yet for this study

Summary

The present multi-disciplinary study will assess blood biomarkers to investigate putative mechanisms of action of ECT. Laboratory findings will be correlated to clinical parameters, cognitive measures and psychometric outcome measures. The aim is to elucidate the underlying mechanisms for both treatment effects and cognitive side effects of ECT.

Conditions

  • Electroconvulsive Therapy
  • Depression
  • Blood Biomarkers

Interventions

OTHER

electroconvulsive therapy

electrical stimulation of the brain while the patient is under anesthesia.

Sponsors & Collaborators

  • Haukeland University Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-01
Primary Completion
2029-10-01
Completion
2029-10-01

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05515159 on ClinicalTrials.gov